🔎 Trials Near Me

Hem › Akut bifentypisk leukemi › Kalifornien

Kliniska studier för Akut bifentypisk leukemi i Kalifornien

15 studier för Akut bifentypisk leukemi söker deltagare vid platser i Kalifornien.

Städer i Kalifornien

Officiell studietext (engelska)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  • City of Hope, Duarte
  • UC Davis, Sacramento
  • Stanford Health Care, Stanford
RekryterarFas 1
Ålder 12 till 78 · Alla kön · Uppdaterad 29 sep. 2026 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Loma Linda University Medical Center, Loma Linda
  • Miller Children's and Women's Hospital Long Beach, Long Beach
  • UCSF Benioff Children's Hospital Oakland, Oakland
  • och 4 fler
RekryterarFas 2
365 Days · Alla kön · Uppdaterad 25 sep. 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Kaiser Permanente Downey Medical Center, Downey
  • City of Hope Comprehensive Cancer Center, Duarte
  • Loma Linda University Medical Center, Loma Linda
  • och 14 fler
RekryterarFas 3
365 Days – 25 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Kaiser Permanente Downey Medical Center, Downey
  • Loma Linda University Medical Center, Loma Linda
  • Miller Children's and Women's Hospital Long Beach, Long Beach
  • och 8 fler
RekryterarFas 1/2
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • City of Hope, Duarte
  • Valkyrie Clinical Trials, Los Angeles
RekryterarFas 1/2
Ålder 13 till 90 · Alla kön · Uppdaterad 6 aug. 2026 · NCT06533579

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

  • Rady Children's Hospital, San Diego
RekryterarFas 1
Ålder 1 till 30 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06177067

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

  • Rady Children's Hospital, San Diego
RekryterarFas 4
Ålder 1 till 18 · Alla kön · Uppdaterad 14 juli 2026 · NCT06289673

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • UCLA Department of Medicine, Los Angeles
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 7 juli 2026 · NCT07216443

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

  • Stanford University, Palo Alto
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 23 juni 2026 · NCT06551584

A Study of Revumenib and Mezigdomide in People With Leukemia

  • City of Hope Cancer Center (Data collection only), Duarte
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 22 juni 2026 · NCT07356154

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  • City of Hope, Duarte
  • Los Angeles Cancer Network, Los Angeles
  • UCLA Medical Center of Hematology/Oncology, Los Angeles
  • och 1 fler
RekryterarFas 1/2
Ålder 12 till 95 · Alla kön · Uppdaterad 15 apr. 2026 · NCT04329728

Venetoclax Basket Trial for High Risk Hematologic Malignancies

  • University of California San Francisco-Benioff Children's Hospital, San Francisco
RekryterarFas 1
Ålder 1 till 40 · Alla kön · Uppdaterad 12 mars 2026 · NCT05292664

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
RekryterarFas 1
Ålder 2 och äldre · Alla kön · Uppdaterad 5 mars 2026 · NCT06575296

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital Orange County, Orange
  • UCSF School of Medicine, San Francisco
RekryterarFas 1
Ålder 1 till 21 · Alla kön · Uppdaterad 6 dec. 2024 · NCT05476770

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.